Dr. Sarah Lisanby has been deeply involved in developing and improving the safety of life-saving neuromodulatory treatments including electroconvulsive therapy (ECT) and magnetic seizure therapy (MST) for severe psychiatric illness.
Read MoreWe are pleased to present you with the 2023 Leading Research Achievements by BBRF Grantees, Prize Winners & Scientific Council Members.
Read MoreDr. Jeffrey Borenstein interviews Dr. Joan Luby of Washington University, St. Louis, whose research has changed views on the subject.
Read MoreA stem cell-based technology provides a unique window on illnesses such as autism and schizophrenia.
Read MoreOn October 28, 2022, we held our International Mental Health Research Symposium.
Read More